Remove Compliance Remove Drug Development Remove Pharmaceuticals
article thumbnail

Key Trends Drug Developers Need to Know to Succeed

PPD

As the pharmaceutical industry continues to evolve, drug developers encounter new challenges and opportunities in their pursuit of innovation. These annual results provide valuable insights into the state of drug development, highlighting shifts in industry practices and illuminating emergent areas of focus.

article thumbnail

ProductLife Group Announces Comprehensive Solution for Pharmaceutical and Biotechnological Product Development at DIA Conference

DS in Pharmatics

Date: June 12, 2024 Location: San Diego, CA ProductLife Group (PLG), a leading provider of product development and compliance services in the pharmaceutical and biotechnological sectors, is excited to announce a comprehensive solution aimed at transforming the landscape of drug development, underscoring PLG's commitment to advancing healthcare through (..)

article thumbnail

Investment Trends in Pharmaceutical Research

DrugBank

Investment Trends in Pharmaceutical Research and Development Investing in the pharmaceutical sector presents a unique set of challenges and opportunities; let’s examine them in more detail.    The average cost of bringing a new drug to market is about $2.6 reported in 2021. trillion by 2028.

article thumbnail

How Sponsors and Sites Work Together to Improve Protocol Compliance

Advarra

Provide Visit Guidance and Calculators to Sites A Tufts Center for the Study of Drug Development (CSDD) study found the mean number of deviations and substantial protocol amendments has increased across all trial phases. The post How Sponsors and Sites Work Together to Improve Protocol Compliance appeared first on Advarra.

article thumbnail

5 Key Benefits of Biopharmaceutical Consulting

DS in Pharmatics

Improve your pharmaceutical product’s chances of success by engaging a biopharmaceutical consultant. These specialists offer essential expertise in drug development, clinical trial design, regulatory compliance, and market strategy.

article thumbnail

Ensuring Quality in Clinical-Phase Drug Manufacturing

thought leadership

Importance of Quality Assurance in Clinical-Phase Drug Manufacturing Quality Assurance (QA) is a critical function in the pharmaceutical industry , ensuring that every aspect of drug manufacturing meets predefined standards of quality.

article thumbnail

Demystifying the ICH M10 Bioanalytical Method Validation Guidelines

Conversations in Drug Development Trends

Developing pharmaceuticals is a complex process, requiring stringent bioanalytical method validation guidelines to ensure drug safety and efficacy. The ICH M10 guidelines aim to streamline this process, reducing redundancy in drug development and facilitating faster access to new therapies.